Selected research
Market Structure
Global Genetic Testing For Neurological Disorders Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Genetic Testing For Neurological Disorders market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Genetic Testing For Neurological Disorders is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Genetic Testing For Neurological Disorders is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Genetic Testing For Neurological Disorders is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Genetic Testing For Neurological Disorders is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Genetic Testing For Neurological Disorders include Illumina, CENTOGENE, Victorian Clinical Genetics Services, PacBio, Mayo Clinic, Quest Diagnostics, MedGenome Labs, GeneDx and Connecticut Children's, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Genetic Testing For Neurological Disorders market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Genetic Testing For Neurological Disorders and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Genetic Testing For Neurological Disorders revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Genetic Testing For Neurological Disorders market size, projected growth trends, production technologies, key applications, and end-use industries.
Genetic Testing For Neurological Disorders Segment by Company
Illumina
CENTOGENE
Victorian Clinical Genetics Services
PacBio
Mayo Clinic
Quest Diagnostics
MedGenome Labs
GeneDx
Connecticut Children's
Labcorp (Invitae/MNG Laboratories)
Genetic Testing For Neurological Disorders Segment by Type
Exome Sequencing
Whole Genome Sequencing
RNA Sequencing
General DNA Testing
Genetic Testing For Neurological Disorders Segment by Application
Hospitals
Specialty Clinics
Diagnostics Laboratories
Genetic Testing For Neurological Disorders Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetic Testing For Neurological Disorders market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Genetic Testing For Neurological Disorders and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetic Testing For Neurological Disorders.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Genetic Testing For Neurological Disorders in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Genetic Testing For Neurological Disorders industry.
Chapter 3: Detailed analysis of Genetic Testing For Neurological Disorders companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Genetic Testing For Neurological Disordersrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Exome Sequencing
- Whole Genome Sequencing
- RNA Sequencing
- General DNA Testing
Applications
- Hospitals
- Specialty Clinics
- Diagnostics Laboratories
Companies covered
- Illumina
- CENTOGENE
- Victorian Clinical Genetics Services
- PacBio
- Mayo Clinic
- Quest Diagnostics
- MedGenome Labs
- GeneDx
- Connecticut Children's
- Labcorp (Invitae/MNG Laboratories)
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Genetic Testing For Neurological Disorders Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Exome Sequencing
- 1.2.3 Whole Genome Sequencing
- 1.2.4 RNA Sequencing
- 1.2.5 General DNA Testing
- 1.3 Market Analysis by Application
- 1.3.1 Global Genetic Testing For Neurological Disorders Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospitals
- 1.3.3 Specialty Clinics
- 1.3.4 Diagnostics Laboratories
- 1.4 Global Market Growth Prospects
- 1.5 Global Genetic Testing For Neurological Disorders Growth Trends by Region
- 1.5.1 Global Genetic Testing For Neurological Disorders Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Genetic Testing For Neurological Disorders Market Size by Region (2021-2026)
- 1.5.3 Genetic Testing For Neurological Disorders Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Genetic Testing For Neurological Disorders Market Dynamics
- 2.1 Genetic Testing For Neurological Disorders Industry Trends
- 2.2 Genetic Testing For Neurological Disorders Industry Drivers
- 2.3 Genetic Testing For Neurological Disorders Industry Opportunities and Challenges
- 2.4 Genetic Testing For Neurological Disorders Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Genetic Testing For Neurological Disorders Revenue by Company (2021-2026)
- 3.2 Global Genetic Testing For Neurological Disorders Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Genetic Testing For Neurological Disorders Key Company Head office and Area Served
- 3.4 Global Genetic Testing For Neurological Disorders Company, Product Type & Application
- 3.5 Global Genetic Testing For Neurological Disorders Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Genetic Testing For Neurological Disorders Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Genetic Testing For Neurological Disorders Players Market Share by Revenue in 2025
- 3.6.3 2025 Genetic Testing For Neurological Disorders Tier 1, Tier 2, and Tier 3
4 Genetic Testing For Neurological Disorders Market by Type
- 4.1 Global Genetic Testing For Neurological Disorders Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Genetic Testing For Neurological Disorders Market Size by Type (2021-2032)
- 4.3 Global Genetic Testing For Neurological Disorders Market Size Share by Type (2021-2032)
5 Genetic Testing For Neurological Disorders Market by Application
- 5.1 Global Genetic Testing For Neurological Disorders Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Genetic Testing For Neurological Disorders Market Size by Application (2021-2032)
- 5.3 Global Genetic Testing For Neurological Disorders Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Illumina
- 6.1.1 Illumina Company Information
- 6.1.2 Illumina Business Overview
- 6.1.3 Illumina Genetic Testing For Neurological Disorders Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Illumina Genetic Testing For Neurological Disorders Product Portfolio
- 6.1.5 Illumina Recent Developments
- 6.2 CENTOGENE
- 6.2.1 CENTOGENE Company Information
- 6.2.2 CENTOGENE Business Overview
- 6.2.3 CENTOGENE Genetic Testing For Neurological Disorders Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 CENTOGENE Genetic Testing For Neurological Disorders Product Portfolio
- 6.2.5 CENTOGENE Recent Developments
- 6.3 Victorian Clinical Genetics Services
- 6.3.1 Victorian Clinical Genetics Services Company Information
- 6.3.2 Victorian Clinical Genetics Services Business Overview
- 6.3.3 Victorian Clinical Genetics Services Genetic Testing For Neurological Disorders Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Victorian Clinical Genetics Services Genetic Testing For Neurological Disorders Product Portfolio
- 6.3.5 Victorian Clinical Genetics Services Recent Developments
- 6.4 PacBio
- 6.4.1 PacBio Company Information
- 6.4.2 PacBio Business Overview
- 6.4.3 PacBio Genetic Testing For Neurological Disorders Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 PacBio Genetic Testing For Neurological Disorders Product Portfolio
- 6.4.5 PacBio Recent Developments
- 6.5 Mayo Clinic
- 6.5.1 Mayo Clinic Company Information
- 6.5.2 Mayo Clinic Business Overview
- 6.5.3 Mayo Clinic Genetic Testing For Neurological Disorders Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Mayo Clinic Genetic Testing For Neurological Disorders Product Portfolio
- 6.5.5 Mayo Clinic Recent Developments
- 6.6 Quest Diagnostics
- 6.6.1 Quest Diagnostics Company Information
- 6.6.2 Quest Diagnostics Business Overview
- 6.6.3 Quest Diagnostics Genetic Testing For Neurological Disorders Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Quest Diagnostics Genetic Testing For Neurological Disorders Product Portfolio
- 6.6.5 Quest Diagnostics Recent Developments
- 6.7 MedGenome Labs
- 6.7.1 MedGenome Labs Company Information
- 6.7.2 MedGenome Labs Business Overview
- 6.7.3 MedGenome Labs Genetic Testing For Neurological Disorders Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 MedGenome Labs Genetic Testing For Neurological Disorders Product Portfolio
- 6.7.5 MedGenome Labs Recent Developments
- 6.8 GeneDx
- 6.8.1 GeneDx Company Information
- 6.8.2 GeneDx Business Overview
- 6.8.3 GeneDx Genetic Testing For Neurological Disorders Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 GeneDx Genetic Testing For Neurological Disorders Product Portfolio
- 6.8.5 GeneDx Recent Developments
- 6.9 Connecticut Children's
- 6.9.1 Connecticut Children's Company Information
- 6.9.2 Connecticut Children's Business Overview
- 6.9.3 Connecticut Children's Genetic Testing For Neurological Disorders Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Connecticut Children's Genetic Testing For Neurological Disorders Product Portfolio
- 6.9.5 Connecticut Children's Recent Developments
- 6.10 Labcorp (Invitae/MNG Laboratories)
- 6.10.1 Labcorp (Invitae/MNG Laboratories) Company Information
- 6.10.2 Labcorp (Invitae/MNG Laboratories) Business Overview
- 6.10.3 Labcorp (Invitae/MNG Laboratories) Genetic Testing For Neurological Disorders Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Labcorp (Invitae/MNG Laboratories) Genetic Testing For Neurological Disorders Product Portfolio
- 6.10.5 Labcorp (Invitae/MNG Laboratories) Recent Developments
7 North America
- 7.1 North America Genetic Testing For Neurological Disorders Market Size (2021-2032)
- 7.2 North America Genetic Testing For Neurological Disorders Market Size by Type
- 7.2.1 North America Genetic Testing For Neurological Disorders Market Size by Type (2021-2026)
- 7.2.2 North America Genetic Testing For Neurological Disorders Market Size by Type (2027-2032)
- 7.2.3 North America Genetic Testing For Neurological Disorders Market Share by Type (2021-2032)
- 7.3 North America Genetic Testing For Neurological Disorders Market Size by Application
- 7.3.1 North America Genetic Testing For Neurological Disorders Market Size by Application (2021-2026)
- 7.3.2 North America Genetic Testing For Neurological Disorders Market Size by Application (2027-2032)
- 7.3.3 North America Genetic Testing For Neurological Disorders Market Share by Application (2021-2032)
- 7.4 North America Genetic Testing For Neurological Disorders Market Size by Country
- 7.4.1 North America Genetic Testing For Neurological Disorders Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Genetic Testing For Neurological Disorders Market Size by Country (2021-2026)
- 7.4.3 North America Genetic Testing For Neurological Disorders Market Size by Country (2027-2032)
- 7.4.4 North America Genetic Testing For Neurological Disorders Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Genetic Testing For Neurological Disorders Market Size (2021-2032)
- 8.2 Europe Genetic Testing For Neurological Disorders Market Size by Type
- 8.2.1 Europe Genetic Testing For Neurological Disorders Market Size by Type (2021-2026)
- 8.2.2 Europe Genetic Testing For Neurological Disorders Market Size by Type (2027-2032)
- 8.2.3 Europe Genetic Testing For Neurological Disorders Market Share by Type (2021-2032)
- 8.3 Europe Genetic Testing For Neurological Disorders Market Size by Application
- 8.3.1 Europe Genetic Testing For Neurological Disorders Market Size by Application (2021-2026)
- 8.3.2 Europe Genetic Testing For Neurological Disorders Market Size by Application (2027-2032)
- 8.3.3 Europe Genetic Testing For Neurological Disorders Market Share by Application (2021-2032)
- 8.4 Europe Genetic Testing For Neurological Disorders Market Size by Country
- 8.4.1 Europe Genetic Testing For Neurological Disorders Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Genetic Testing For Neurological Disorders Market Size by Country (2021-2026)
- 8.4.3 Europe Genetic Testing For Neurological Disorders Market Size by Country (2027-2032)
- 8.4.4 Europe Genetic Testing For Neurological Disorders Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Genetic Testing For Neurological Disorders Market Size (2021-2032)
- 9.2 China Genetic Testing For Neurological Disorders Market Size by Type
- 9.2.1 China Genetic Testing For Neurological Disorders Market Size by Type (2021-2026)
- 9.2.2 China Genetic Testing For Neurological Disorders Market Size by Type (2027-2032)
- 9.2.3 China Genetic Testing For Neurological Disorders Market Share by Type (2021-2032)
- 9.3 China Genetic Testing For Neurological Disorders Market Size by Application
- 9.3.1 China Genetic Testing For Neurological Disorders Market Size by Application (2021-2026)
- 9.3.2 China Genetic Testing For Neurological Disorders Market Size by Application (2027-2032)
- 9.3.3 China Genetic Testing For Neurological Disorders Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Genetic Testing For Neurological Disorders Market Size (2021-2032)
- 10.2 Asia Genetic Testing For Neurological Disorders Market Size by Type
- 10.2.1 Asia Genetic Testing For Neurological Disorders Market Size by Type (2021-2026)
- 10.2.2 Asia Genetic Testing For Neurological Disorders Market Size by Type (2027-2032)
- 10.2.3 Asia Genetic Testing For Neurological Disorders Market Share by Type (2021-2032)
- 10.3 Asia Genetic Testing For Neurological Disorders Market Size by Application
- 10.3.1 Asia Genetic Testing For Neurological Disorders Market Size by Application (2021-2026)
- 10.3.2 Asia Genetic Testing For Neurological Disorders Market Size by Application (2027-2032)
- 10.3.3 Asia Genetic Testing For Neurological Disorders Market Share by Application (2021-2032)
- 10.4 Asia Genetic Testing For Neurological Disorders Market Size by Country
- 10.4.1 Asia Genetic Testing For Neurological Disorders Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Genetic Testing For Neurological Disorders Market Size by Country (2021-2026)
- 10.4.3 Asia Genetic Testing For Neurological Disorders Market Size by Country (2027-2032)
- 10.4.4 Asia Genetic Testing For Neurological Disorders Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Genetic Testing For Neurological Disorders Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Type
- 11.2.1 South America, Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Genetic Testing For Neurological Disorders Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Application
- 11.3.1 South America, Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Genetic Testing For Neurological Disorders Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Country
- 11.4.1 South America, Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Genetic Testing For Neurological Disorders Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Genetic Testing For Neurological Disorders Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst